Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.75% | 17.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.98% | 18.75% | |||
| Operating Income | 17.98% | -18.75% | |||
| Income Before Tax | 2.26% | -18.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.26% | -18.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.26% | -18.85% | |||
| EBIT | 17.98% | -18.75% | |||
| EBITDA | 19.43% | -21.04% | |||
| EPS Basic | 2.86% | -7.71% | |||
| Normalized Basic EPS | 18.34% | -7.69% | |||
| EPS Diluted | 2.86% | -7.71% | |||
| Normalized Diluted EPS | 18.34% | -7.69% | |||
| Average Basic Shares Outstanding | 0.65% | 10.09% | |||
| Average Diluted Shares Outstanding | 0.65% | 10.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | -- | |||